NCT06612671View on ClinicalTrials.gov

Treatment Outcomes of Retroperitoneal Sarcoma

Active, not recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

September 30, 2025

Conditions
Retroperitoneal Sarcoma
Interventions
PROCEDURE

tumor wide excision

patients received properative or post-operative radiotherapy

Trial Locations (1)

Unknown

Taichung Veterans General Hospital, Taichung

All Listed Sponsors
lead

Taichung Veterans General Hospital

OTHER

NCT06612671 - Treatment Outcomes of Retroperitoneal Sarcoma | Biotech Hunter | Biotech Hunter